Fact sheet Lung cancer screening for employees exposed to asbestos using CT screening (CTTS)

Size: px
Start display at page:

Download "Fact sheet Lung cancer screening for employees exposed to asbestos using CT screening (CTTS)"

Transcription

1 Version: February 2013 Fact sheet Lung cancer screening for employees exposed to asbestos using CT screening (CTTS) Dr. med. Susanna Stöhr, PD Dr. med. Dr. phil. David Miedinger, Dr. med. Marcel Jost 1. Situation prior to 2011 Asbestos-related changes and diseases - such as lung cancers (bronchial carcinoma) and mesothelioma - are usually associated with macroscopically discernible tissue neoplasms. For screening tests, priority is therefore given to imaging techniques. The screening studies carried out in the 1970s to detect lung cancer among smokers - the main risk group - using the X-ray technology of that time were disappointing as these studies failed to reduce lung cancer mortality. For this reason, no recommendation for lung cancer screening with plain chest ray studies were given over the next two decades. At an international conference on the prevention and early detection of bronchial carcinoma held in Varese in 1998, it was found that the effectiveness of the screening of this common tumor, which is mainly caused by smoking, should be explored with the help of newer imaging techniques, particularly computer tomography (CT). For the diagnosis of bronchial carcinoma, computer tomography of the thoracic organs is superior in terms of sensitivity and specificity to conventional X-rays. The goal of screening is to detect a disease at an early stage. It is known from the literature that surgically treated bronchial carcinoma at stage I have a much better five-year survival than in later stages. The use of CT, in particular using low irradiation-dose and spiral technique, has shown that among older smokers in particular, as well as among people previously exposed to asbestos, lung tumors can be detected more frequently and at earlier stages, which is reflected in an improved five-year survival period. In 2000, Henschke et al. published the first in a series of publications in which it could be shown that bronchial carcinoma can be diagnosed at an early stage among smokers over the age of 60 using low-dose spiral CT technology, i.e. to the extent of 85% in stage I. Among 233 of 1,000 subjects, a total of 559 nodules was found, 28 of which were shown by biopsy to be malignant tumors. An algorithm with phased follow-up investigations together with volume calculations made it possible to limit the number of cases to be clarified by biopsy to a minimum. The investigation carried out in the International Early Lung Cancer Action Program (IELCAP) showed that bronchial carcinoma can be discovered at an early stage (stage I) by spiral CT screening. In this study conducted among more than 30,000 people over the age of 40 and with an increased risk of lung cancer due to smoking, passive smoking and occupational exposure to carcinogenic agents, lung cancer in stage I was found in 85% of the patients

2 - 2 - affected and the estimated 10-year survival rate was 88% in this subgroup. The study concluded that annual spiral CT screening can recognize lung cancers in a stage in which they can often be cured. A study published in 2007 by Bach et al. showed that while more new bronchial carcinoma can be discovered with CT screening, the number of cases of advanced bronchial carcinoma and mortality resulting from bronchial carcinoma may not be reduced by CT screening. An overview of current and planned randomized controlled studies on low dose- CT screening by the University of Lausanne in 2007 concluded that systematic CT screening should only be considered if controlled, randomized studies show a decrease in mortality due to screening. CT-based screening for the early detection of lung tumors has also been carried out among people previously exposed to asbestos. Tiitola et al. found 111 nodules of > 0.5 cm in size, 6 of which in the end proved to be bronchial carcinoma, among 602 people previously exposed to asbestos (97% of them were smokers). In a CT screening study published in also from Finland (Vierikko et al.) - HRCT and CT investigations were used to detect a noncalcified nodule among 86 of 633 former workers exposed to asbestos, which in five cases were histologically proven to be bronchial carcinoma. Two were in stage Ia, three in stage IIIb. In addition, 343 additional findings, of which 46 had to be further clarified, were identified among the total of 277 subjects. A multicenter study from Italy (Fasola et al.) conducted in 2007 among employees previously exposed to asbestos showed that CT screening among people previously exposed to asbestos produces similar results to those among smokers. It was noted that only the randomized controlled investigations show whether a reduction in mortality caused by bronchial carcinoma can be achieved by low-dose CT screening. As part of the Asbestos Surveillance Program Aachen (ASPA), 187 people from a group of over 5,000 former powerplant employees with a particularly high risk of lung cancer due to exposure to asbestos, smoking and old age were studied prospectively (Das M. et al.). Asbestos-related changes of the pleura and the lungs were observed among 43% of the people. Among 8/187 employees, that is to say 4%, lung cancer was detected in the first examination. Within the framework of this screening, a high number of additional nodular changes was observed and only 12% of the subjects had no nodular changes. The high prevalence of lung cancer in the Aachen monitoring program shows that the inclusion criteria for screening were well chosen. Mastrangelo et al. studied 1,119 employees previously exposed to asbestos; in the group studied, the risk of lung cancer was not greater compared to the general population and the screening program was not judged to be cost-effective. Experience with CT screening in Canada was published by Roberts et al. in An increased sensitivity of chest CT compared with the conventional radiography for the detection of lung cancers was described by Clin et al. in France in In 2009, a randomized controlled study of 2,472 people was published under the name of the Dante trial. It included men aged between 60 and 75 with a cigarette consumption of 20 or more pack-years. Annual screening with a low spiral CT was compared to an annual medical examination (without chest x-ray). Lung cancer was found in 4.7% of persons using CT screening and 2.8% of the other people; in the group with CT screening, more lung cancer in stage I was observed compared with the controls (54% versus 34%). With a figure of 1.6%, mortality from lung cancer was not significantly lower in the CT screening group compared to the control group at 1.7%. The study authors concluded that lung cancer screening with lowdose spiral CT should not yet be performed outside of studies.

3 - 3 - The psychological impact of lung cancer screening among employees exposed to asbestos was investigated by Vierikko et al. in Finland; the results were published in Among 633 employees examined using CT screening, no significant psychological differences (such as increased anxiety regarding their personal health) were observed after one year between employees with normal findings and employees among whom additional tests after CT screening became necessary. These encouraging results were confirmed in another study in Holland and Belgium among participants of the NELSON program. Among participants among whom findings were noted during the first examination and which required further clarification, a slight temporary impairment of quality of life due to uncertainty was, identified. However, further investigation two years later showed that this impairment was no longer measurable. 2. The NLST trial 2011 The largest randomized controlled study investigating whether overall mortality and specific lung cancer mortality can be reduced in persons with an elevated risk of lung cancer by regular screening with low-dose spiral CT is the National Lung Screening Trial (NLST). Itinvestigated more than 53,000 smokers and ex-smokers aged between 55 and 74. Smokers with at least 30 pack-years were included in the study. One group was investigated with low-dose spiral CT and the control group with chest radiographs. A press release issued by the NLST in November 2010 claimed that overall mortality in the group with annual low-dose spiral CT was 7% lower than in the control group and that lung-cancer specific mortality was 20% lower in the group with low-dose spiral CT. In this study, 26,723 participants in a low-dose CT group were investigated using a low-dose spiral CT once a year for 3 years and then monitored for another 3.5 years. In the comparison group, 26,733 participants were examined and observed by a chest x-ray using the same timeframe. All three investigations were carried out among 95% in the CT group and 93% in the X-ray group. In each of the three time points in the investigation, far more positive results, these being about three times as often, were obtained with low-dose spiral CT than in the group with the X-ray examination. However, only 2% to 7% of the radiological findings suggestive of lung cancer actually proved to be malignant tumors. The clarification of positive results was usually handled by consulting former radiological studies and invasive investigations were not often necessary. In those who needed further clarifications, very few complications due to invasive exams had occurred (1.4% in the group receiving low-dose spiral CT). More serious complications after invasive investigations among participants without any resultant lung cancer occurred among 0.06% of the participants in the group receiving low-dose spiral CT. In the group receiving low-dose spiral CT, more lung cancer was observed in a stage IA and IB less advanced lung cancer in stage IV than in the group receiving conventional chest x-ray. Small-cell lung cancer was detected at an early stage neither in the group receiving low-dose spiral CT nor X-ray examination. Lung-cancer specific mortality was lower by 20.0% and total mortality by 6.7 % in the group with low-dose spiral CT. The authors conclude that the efficacy of low-dose spiral CT screening may possibly be even greater than the study suggests. On the one hand, better scanners are used today than at the time of the studies (August 2002 to April 2004). On the other hand, the effect of reducing mortality might be even higher as a result of extending the observation period after the end of the CT screening.

4 - 4 - However, the publication of the NLST in summer 2011 cannot yet answer some important questions such as the question as to how long a CT screening is to be performed, whether a CT screening with larger intervals is also effective and to what extent people with lower risks than those represented by the NLST inclusion criteria can benefit from a CT screening. While complications resulting from clarifications, particularly severe complications, were rarely observed in the NLST, the question of the association between low-dose spiral CT screening and the incidence of radiation-induced malignancies cannot be answered by the study. It is also worth mentioning in this context that the medical centers participating had a wealth of experience regarding the clarification and treatment of bronchial tumors and that results in another medical context (non-university clinics, pulmonologists in private practices) are still missing. The NLST will publish further evaluations regarding the costs/benefits of low-dose spiral CT screening and the effect on participants quality of life. Other issues such as the effectiveness of prolonged CT screening programs will only be definitely answered after the publication of further controlled randomized trials in Europe and their evaluations in meta-analyses. The authors of the NLST come to the conclusion that, before the decision to initiate a low-dose spiral CT screening on a large scale, we must wait for the analyses of costs and benefits and the reduction in lung cancer-specific mortality compared with the side-effects of CT screening. They also note that the costs/benefits of low-dose CT screening must be seen in the context of other interventions, particularly smoking cessation. In the relevant editorial in the New England Journal of Medicine in the summer of 2011, H.C. Sox basically also supports the opinion that Policy makers should wait for cost-effectiveness analyses of the NLST data, further follow-up data to determine the amount of overdiagnosis in the NLST, and perhaps, identification of biologic markers of cancers that do not progress. He also notes: Systematic reviews that include other, smaller lung-cancer screening trials will provide an overview of the entire body of evidence. The results of the NLST have led to recommendations from organizations such as the National Comprehensive Cancer Network NCCN and the American Association for Thoracic Surgery. The NCCN guidelines on lung cancer prevention note that "The NCCN Lung Cancer Screening panel recommends spiral LDCT screening for select patients at high risk for lung cancer based on the NLST results, non-randomized studies, and observational data". Criteria for the inclusion of lung-cancer screening are described by the NCCN. In these guidelines, it is emphasized that smokers should always be encouraged to give up smoking. The American Association for Thoracic Surgery also published guidelines for CT lung cancer screening among people with high risks in Lung cancer prevention among employees exposed to asbestos by means of CTscreening (CTTS) 3.1 Conclusions drawn from the NLST study for occupational health screening Until 2011, effective occupational health screening for employees with exposure to asbestos was only possible for the detection and monitoring of benign asbestos occupational diseases and their consequences; effective occupational healthcare for the reduction of mortality caused by mesothelioma, i.e. by particularly malignant tumors of the pleura and peritoneum, is still not possible today.

5 - 5 - Because of the NLST study, the risk of mortality for people with a significantly increased risk of lung cancer can be reduced with the use of low-dose spiral CT by being able to detect lung cancer at an earlier stage in which there are effective treatment options as well as the prospect of a complete cure. However, compared to a typical X-ray image, computer tomography involves a higher radiation dose. This exposure to radiation, which is higher than a conventional X-ray image, appears to be justified given the option of better and earlier identification of pathological findings. Due to the greater sensitivity of CT over conventional radiography, however, it is also possible to obtain findings that, while they are not morbid, nevertheless require clarification; these false-positive findings due to the further clarification are the most frequent to be expected especially during the earliest investigations. For lung cancer prevention among workers exposed to asbestos using CT screening (CTTS), it must be noted that the results of the NLST apply to high, relative risks for lung cancer (more than 30 pack-years nicotine consumption) and the age category of 55 to 75. Based on scientific evidence, a CTTS can thus be performed in line with the risk, which means that the tests are recommended to persons among whom similarly high risks such as the increased cancer risk in the NLST study can be assumed due to asbestos exposure and smoking. Here, the super-additive effect of smoking and asbestos must be taken into account. The results of the NLST study are based on three investigation cycles on an annual basis and a subsequent observation period of three and a half years. This does not permit any statement to be made on the value of further investigation cycles that go beyond the three years. The issue of CT screening over several years must therefore be reassessed at a later time based on further results of randomized controlled trials on a CT screening and the experience of lung cancer screening in Switzerland and abroad. The Helsinki criteria are the determining factors for the recognition of lung cancer after exposure to asbestos, (q.v. fact sheet issued by Suva s Department of Occupational Medicine Asbestos-related diseases ). Recognition of lung cancer after asbestos exposure as an occupational disease is not dependent on whether CT screening is recommended and implemented. When lung cancer is diagnosed in the context of CT screening, the causality is thus assessed as in other situations based on the Helsinki criteria, which means that not every lung cancer detected by CT screening can be recognized as an occupational disease. The question of using a low-dose spiral CT within the framework of the occupational health screening of employees exposed to asbestos has to take into consideration a context that is different from the question of whether a CT screening is to be offered to heavy smokers in the general population. Compared to the large group of heavy smokers in the general population, the group of employees relevantly exposed to asbestos is significantly smaller; for those with previous exposure to asbestos, stopping smoking is only a part of risk reduction. While the wait for the results of further controlled randomized trials and their meta-analyses for many years is an option for the question of the introduction of CT screening among smokers, in the case of asbestos-related malignant neoplasms, the peak of the number of patients affected by malignant neoplasms is expected between 2015 and the effectiveness of CT screening is thus best in the years ahead. With regard to the question of the introduction of CT screening in the case of people exposed to asbestos, ethical issues or society's responsibility for the increased risk for malignant neoplasms should be included in the consideration. After all, employees exposed to asbestos not only continue to undergo radiological investigation for the

6 - 6 - early detection of lung cancer, but also with regard to the incidence of other benign and malignant illnesses. In this regard, we refer to the overview of the subsequent investigations of employees after exposure to asbestos by A. Massardier-Pilonchery and A. Bergeret and the work of T.Vierikko et al Lung cancer screening at Suva Through the medium of a personal letter, Suva recommends people aged between 55 and 75 to have a CT screening either as part of occupational healthcare or with asbestos-related occupational diseases if - as a result of exposure to asbestos alone or as a result of exposure to asbestos and smoking together - there is an increased risk of lung cancer that corresponds to smoking 30 pack-years, i.e. the inclusion criteria of the NLST. In the event of exposure to asbestos alone, i.e. among non-smokers, a CT screening is also recommended if lung cancer were recognized as an occupational disease, i.e. in the presence of the Helsinki criteria (see asbestos fact sheet). Due to the super-additive effect of asbestos exposure and smoking, a CT screening is also recommended if a higher lung cancer risk in the range of the NLST s risk is present without the Helsinki criteria being met. Within the framework of occupational healthcare, Suva informs employees and people with asbestos-related occupational diseases by newsletter on the offer of a CT screening. The examination with computer tomography recommended by Suva is voluntary for these people. Employees have an opportunity to discuss their situation with a pulmonologist in the department of occupational medicine. As part of occupational healthcare for employees, a CT scan is performed annually, analyzed by an X-ray specialist and, in the presence of findings requiring clarification, discussed with a lung specialist. The doctors responsible (GPs, occupational healthcare physicians and pulmonary specialists) are informed of the findings by the X-ray department. As before, the medical history is obtained, a clinical exam of the heart and lungs, and a lung function test are carried out every two years by the doctor for a medical prophylactic examination. In the case of people with asbestos-related occupational diseases, Suva usually demands to perform medical history taking, a clinical examination of the heart and lungs as well as lung function tests by the family doctor or a pulmonary specialist every year. In addition, a CT scan is performed each year. The procedure for information corresponds to the one for occupational health screening.

7 - 7 - Further reading Anonymous: Official statement of the Varese Conference on Prevention and Early Diagnosis of Lung Cancer. Lung Cancer Frontiers (1999); 5 (Newsletter) Ashraf H. et al.: Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax 2009; 64: Bach P.B. et al.: Computed tomography screening and lung cancer outcomes. JAMA 2007; 297: Black W.C., Baron J.A.: CT Screening for Lung Cancer: Spiraling Into Confusion? JAMA (2007): 297: Clin B. et al.: Performance of chest radiograph and CT scan for lung cancer screening in asbestos-exposed workers. Occup Environ Med 2009: 66: Das M. et al.: Asbestos Surveillance Program Aachen (ASPA): initial results from baseline screening for lung cancer in asbestosexposed high-risk individuals using low-dose multidetector-row CT. Eur Radiol 2007: 17: Fasola G. et al.: Low-Dose Computed Tomography Screening for Lung Cancer and Pleural Mesothelioma in an Asbestos-Exposed Population: Baseline Results of a Prospective, Nonrandomized Feasibility Trial. The Oncologist (2007): 12: Gohagan J. et al.: Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan versus chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest (2004); 126: Guessous I., Cornuz J.,Paccaud F.,: Lung cancer screening: current situation and perspective. Swiss Medical Weekly (2007); 137: Hagemeyer O. et al.: Krebsfrüherkennung verspricht bessere Heilungschancen. IPA-Journal 2012; 02: Henschke C.I.: Early Lung Cancer Action Project. Cancer (2000); Supplement 89: Heyneman L.E. et al.: Stage distribution in patients with a small (< or = 3cm) primary nonsmall cell lung carcinoma. Implication for lung carcinoma screening. Cancer (2001); 92: Infante M. et al.: A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. Am J Respir Crit Care Med 2009; 180: Jaklitsch M.T. et al.: The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012; 144: Lopes Pegna A. et al.: Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009; 64: Massardier-Pilonchery A., Bergeret A.: Suivi après exposition professionnelle à l'amiante: modalitiés et dispositifs étrangers. Revue des Maladies Respiratoires 2011; 28:

8 - 8 - Mastrangelo G. et al.: Feasibility of a screening programme for lung cancer in former asbestos workers. Occupational Medicine 2008: 58: Mc Mahon P.M. et al.: Estimating long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study Radiology 2008;10:1148 ff National Comprehensive Cancer Network NCCN: Lung Cancer Screening. Patz E.F. et al.: Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest (2000); 117: Roberts H.C. et al.: Screening for Malignant Pleural Mesothelioma and Lung Cancer in Individuals with a History of Asbestos Exposure. J Thorac Oncol 2009; 4: Sox H.C.: Better Evidence about Screening for Lung Cancer. N Engl J Med; 365:5, Strauss G.M. et al.: Como International Conference Position Statement. Chest (2005); 127: The National Lung Screening Trial Research Team Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med 2011; 365: Tiitola M. et al.: Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer (2002); 35: The International Early Lung Cancer Action Programm Investigators: Survival of Patients with Stage I Lung Cancer Detected on CT Screening. N Engl J Med (2006): 35: Van den Bergh K.A.M. et al.: Long-term effects of lung cancer computed tomography screening on health related quality of life: the NELSON trial. Eur Respir J 2011; 38: Van Iersel C.A. et al.: Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007; 120: Vierikko T. et al.: Chest CT screening of asbestos-exposed workers: lung lesions and incidental findings. Eur Resp J 2007; 29: Vierikko T. et al.: Psychological impact of computed tomography screening for lung cancer and occupational pulmonary disease among asbestos-exposed workers. European Journal of Cancer Prevention 2009; 18: Vierikko T. et al.: Clinical and HRCT screening of heavily asbestos-exposed workers. Int Arch Occup Environ Health 2010; 83: 47-54

Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital

Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Lung Cancer Screening with Low-dose CT Imaging Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Despite recent declines in the incidence of lung cancer related to the

More information

Lung Cancer Screening

Lung Cancer Screening Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at

More information

Screening for asbestos-related lung cancer Nea Malila, Tony Miller, Riitta Sauni, Robert Smith, Kurt Straif, Tapio Vehmas

Screening for asbestos-related lung cancer Nea Malila, Tony Miller, Riitta Sauni, Robert Smith, Kurt Straif, Tapio Vehmas Screening for asbestos-related lung cancer Nea Malila, Tony Miller, Riitta Sauni, Robert Smith, Kurt Straif, Tapio Vehmas International Conference on Monitoring and Surveillance of Asbestos-Related Diseases

More information

MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock Manchester 100 Hitchcock Way Manchester, NH 03104 (603) 695-2850

MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock Manchester 100 Hitchcock Way Manchester, NH 03104 (603) 695-2850 LEBANON Lung Cancer Screening Program One Medical Center Drive Lebanon, NH 03756 (603) 650-4400 (866) 966-1601 Toll-free cancer.dartmouth.edu/lungscreening MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock

More information

HEALTH CARE FOR EXPOSURE TO ASBESTOS. 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun.

HEALTH CARE FOR EXPOSURE TO ASBESTOS. 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun. HEALTH CARE FOR PATIENTS WITH EXPOSURE TO ASBESTOS 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun.ca HEALTH CARE FOR PATIENTS WITH EXPOSURE

More information

Report of Working Groups

Report of Working Groups BD5.3 Report of Working Groups Elimination of Asbestos-related Diseases ICOH 2012 March 18, 2012 Cancun Report of WG Elimination of Asbestos-related Diseases Dr. Sherson mail to ICOH President of 7 December

More information

Stephen R. Veach, M.D.

Stephen R. Veach, M.D. Stephen R. Veach, M.D. Memorial Sloan-Kettering Cancer Center International Oncology Programs 160 E. 53 rd Street New York, NY 10022 212-610 610-08780878 - tel 212-308 308-7063 - fax veachs@mskcc.org SCREENING

More information

Lung Cancer Screening

Lung Cancer Screening Lung Cancer Screening Middlesex Hospital Total Lung Care Center Megin Iaccarino RN, BSN Lung Pathway Coordinator and Lung Nurse Navigator Middlesex Hospital Cancer Center and Surgical Alliance Lung Screening

More information

Lung Cancer Screening: An Update for the U.S. Preventive Services Task Force

Lung Cancer Screening: An Update for the U.S. Preventive Services Task Force This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or a basis for reimbursement and coverage policies. AHRQ

More information

What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide

What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide A M E R I C A N C O L L E G E O F C H E S T P H Y S I C I A N S Lung cancer is one of the most common cancers. About 170,000

More information

An Update on Lung Cancer Diagnosis

An Update on Lung Cancer Diagnosis An Update on Lung Cancer Diagnosis Dr Michael Fanning MBBS FRACGP FRACP RESPIRATORY AND SLEEP PHYSICIAN Mater Medical Centre Outline Risk factors for lung cancer Screening for lung cancer Radiologic follow-up

More information

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD Epidemiology, Staging and Treatment of Lung Cancer Mark A. Socinski, MD Associate Professor of Medicine Multidisciplinary Thoracic Oncology Program Lineberger Comprehensive Cancer Center University of

More information

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200 GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung

More information

Is CT screening for asbestos-related diseases rational?

Is CT screening for asbestos-related diseases rational? Is CT screening for asbestos-related diseases rational? Narufumi Suganuma, M.D. 1 Yukinori Kusaka, M.D. 1 Harumi Itoh, M.D. 2 1 Division of Environmental Health, Department of International, Social and

More information

Occupational respiratory diseases due to Asbestos. Dirk Dahmann, IGF, Bochum

Occupational respiratory diseases due to Asbestos. Dirk Dahmann, IGF, Bochum Occupational respiratory diseases due to Asbestos Dirk Dahmann, IGF, Bochum Contents Introduction Diseases Further Effects Preventive Strategies Conclusion Asbestos minerals Woitowitz, 2003 Imports (+

More information

Cigna Medical Coverage Policy

Cigna Medical Coverage Policy Cigna Medical Coverage Policy Subject Low-Dose Computed Tomography for Lung Cancer Screening Effective Date... 2/15/2014 Next Review Date... 2/15/2015 Coverage Policy Number... 0007 Table of Contents Coverage

More information

Clinical Trials and Screening: What You Need to Know

Clinical Trials and Screening: What You Need to Know Scan for mobile link. Clinical Trials and Screening: What You Need to Know What is a Clinical Trial? At A Glance A clinical trial is a research study that tests how well new medical techniques work in

More information

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology Mesothelioma 1. Introduction 1.1 General Information and Aetiology Mesotheliomas are tumours that arise from the mesothelial cells of the pleura, peritoneum, pericardium or tunica vaginalis [1]. Most are

More information

Danish Lung Cancer Screening Trial (DLCST).

Danish Lung Cancer Screening Trial (DLCST). Danish Lung Cancer Screening Trial (DLCST). Röntgenveckan, Karlstad 11.september 2014 Jesper Holst Pedersen, MD, DMsci, Associate Professor Rigshospitalet University of Copenhagen, Denmark DLCST (Danish

More information

LOW DOSE CT LUNG CANCER SCREENING: IT S TIME HAS COME. Andrew D. Nish MD

LOW DOSE CT LUNG CANCER SCREENING: IT S TIME HAS COME. Andrew D. Nish MD LOW DOSE CT LUNG CANCER SCREENING: IT S TIME HAS COME Andrew D. Nish MD OBJECTIVES Understand the controversies of screening for cancer control in a large population Understand primary and secondary prevention

More information

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing ASBESTOSIS November 2013 Bruce T. Bishop Lucy L. Brandon Willcox & Savage 440

More information

Asbestos related cancers

Asbestos related cancers New cancer cases 1954-215 in Finland, Men Pukkala et al. 26 Asbestos related cancers Panu Oksa, MD, docent Course on asbestos-related diseases Tartu 4-5.12.26 Asbestos related cancer / FIOH / PO / 1.1.27

More information

National Framework for Excellence in

National Framework for Excellence in National Framework for Excellence in Lung Cancer Screening and Continuum of Care declaration of purpose Rights and Expectations THE RIGHTS OF THE PEOPLE Lung cancer kills more Americans than the next four

More information

Health effects of occupational exposure to asbestos dust

Health effects of occupational exposure to asbestos dust Health effects of occupational exposure to asbestos dust Authors: N.Szeszenia-Dąbrowska, U.Wilczyńska The major health effects of workers' exposure to asbestos dust include asbestosis, lung cancer and

More information

Lung cancer forms in tissues of the lung, usually in the cells lining air passages.

Lung cancer forms in tissues of the lung, usually in the cells lining air passages. Scan for mobile link. Lung Cancer Lung cancer usually forms in the tissue cells lining the air passages within the lungs. The two main types are small-cell lung cancer (usually found in cigarette smokers)

More information

Risk factors associated with asbestos-related diseases: results of the asbestos surveillance programme Aachen

Risk factors associated with asbestos-related diseases: results of the asbestos surveillance programme Aachen Risk factors associated with asbestos-related diseases: results of the asbestos surveillance programme Aachen KHATAB, Khaled, FELTEN, Michael K., KANDALA, Nagianga B., GHILAGABER, Gebrenegus, GUMBER, Anil

More information

Asbestos Related Diseases

Asbestos Related Diseases Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease Asbestosis and Mesothelioma (LUNG CANCER) Support Group 1800 017 758 www.amsg.com.au ii Helping you and your family through

More information

Mesothelioma. 1995-2013, The Patient Education Institute, Inc. www.x-plain.com ocft0101 Last reviewed: 03/21/2013 1

Mesothelioma. 1995-2013, The Patient Education Institute, Inc. www.x-plain.com ocft0101 Last reviewed: 03/21/2013 1 Mesothelioma Introduction Mesothelioma is a type of cancer. It starts in the tissue that lines your lungs, stomach, heart, and other organs. This tissue is called mesothelium. Most people who get this

More information

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,

More information

ONLINE CONTINUING EDUCATION ACTIVITY

ONLINE CONTINUING EDUCATION ACTIVITY ARTICLE TITLE: American Cancer Society Lung Cancer Screening Guidelines ONLINE CONTINUING EDUCATION ACTIVITY Take free quizzes online at acsjournals.com/ce CONTINUING MEDICAL EDUCATION ACCREDITATION AND

More information

Asbestos Disease: An Overview for Clinicians Asbestos Exposure

Asbestos Disease: An Overview for Clinicians Asbestos Exposure Asbestos Asbestos Disease: An Overview for Clinicians Asbestos Exposure Asbestos: A health hazard Exposure to asbestos was a major occupational health hazard in the United States. The first large-scale

More information

Treatment Guide Lung Cancer Management

Treatment Guide Lung Cancer Management Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular

More information

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT

More information

Mesothelioma: Questions and Answers

Mesothelioma: Questions and Answers CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions

More information

This factsheet aims to outline the characteristics of some rare lung cancers, and highlight where each type of lung cancer may be different.

This factsheet aims to outline the characteristics of some rare lung cancers, and highlight where each type of lung cancer may be different. There are several different kinds of lung cancer, often referred to as lung cancer subtypes. Some of these occur more often than others. In this factsheet we will specifically look at the subtypes of cancers

More information

The Evaluation of Cancer Control Interventions in Lung Cancer Using a Canadian Cancer Risk Management Model

The Evaluation of Cancer Control Interventions in Lung Cancer Using a Canadian Cancer Risk Management Model The Evaluation of Cancer Control Interventions in Lung Cancer Using a Canadian Cancer Risk Management Model WK Evans, M Wolfson, WM Flanagan, J Shin, FF Liu JR Goffin, K Asakawa, N Mittmann, L Fairclough

More information

Survivorship Care Plans Guides for Living After Cancer Treatment

Survivorship Care Plans Guides for Living After Cancer Treatment Survivorship Care Plans Guides for Living After Cancer Treatment Institute of Medicine Report 2005 Recommendations for meeting needs of cancer survivors Implement survivorship care plan Build bridges

More information

Testimony of. Dr. James Crapo. April 26, 2005

Testimony of. Dr. James Crapo. April 26, 2005 Testimony of Dr. James Crapo April 26, 2005 Written Statement of Dr. James D. Crapo, Professor of Medicine, National Jewish Medical and Research Center and University of Colorado Health Sciences Center

More information

Asbestos Related Diseases. Asbestosis Mesothelioma Lung Cancer Pleural Disease. connecting raising awareness supporting advocating

Asbestos Related Diseases. Asbestosis Mesothelioma Lung Cancer Pleural Disease. connecting raising awareness supporting advocating Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease connecting raising awareness supporting advocating 1800 017 758 www.asbestosassociation.com.au Asbestos lagging was widely

More information

PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj.

PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj. PSA Testing 101 Stanley H. Weiss, MD Professor, UMDNJ-New Jersey Medical School Director & PI, Essex County Cancer Coalition weiss@umdnj.edu September 23, 2010 Screening: 3 tests for PCa A good screening

More information

INSTRUCTIONS FOR FILING A CLAIM WITH THE CELOTEX ASBESTOS SETTLEMENT TRUST

INSTRUCTIONS FOR FILING A CLAIM WITH THE CELOTEX ASBESTOS SETTLEMENT TRUST INSTRUCTIONS FOR FILING A CLAIM WITH THE CELOTEX ASBESTOS SETTLEMENT TRUST The Celotex Asbestos Settlement Trust (Celotex Trust) was established as a result of the bankruptcy of the Celotex Corporation

More information

Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer About Your Lungs and Lung Cancer How do your lungs work? To understand lung cancer it is helpful to understand your lungs. Your lungs put oxygen into the blood, which the heart

More information

MEDICAL SCREENING PROTOCOL FOR THE FORMER WORKER MEDICAL SCREENING PROGRAM U.S. DEPARTMENT OF ENERGY

MEDICAL SCREENING PROTOCOL FOR THE FORMER WORKER MEDICAL SCREENING PROGRAM U.S. DEPARTMENT OF ENERGY MEDICAL SCREENING PROTOCOL FOR THE FORMER WORKER MEDICAL SCREENING PROGRAM U.S. DEPARTMENT OF ENERGY General Principles: 1) The purpose of the medical evaluation component of the U.S. Department of Energy

More information

Male. Female. Death rates from lung cancer in USA

Male. Female. Death rates from lung cancer in USA Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita

More information

Lung Cancer & Mesothelioma 2011-2015

Lung Cancer & Mesothelioma 2011-2015 Lung Cancer & Mesothelioma 2011-2015 Annex G Mesothelioma 1. The vision for mesothelioma services is set out in the Mesothelioma Framework issued by DH on 26 February 2007 (supported by the British Thoracic

More information

Primary -Benign - Malignant Secondary

Primary -Benign - Malignant Secondary TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low

More information

Lung Cancer Consultant Outcomes Publication

Lung Cancer Consultant Outcomes Publication Lung Cancer Consultant Outcomes Publication Introduction This report describes the outcomes of individual consultant thoracic and cardiothoracic surgeons who carry out surgery for lung cancer. It has been

More information

SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL

SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL S.B. 15, the asbestos/silica litigation reform bill, distinguishes between the claims of people who are physically impaired or sick due to exposure

More information

New Frontiers to Cancer Care Symposium. Lung Cancer Screening Update: Pros, Cons, and Understanding the CMS Requirements

New Frontiers to Cancer Care Symposium. Lung Cancer Screening Update: Pros, Cons, and Understanding the CMS Requirements Thursday October 15, 2015 New Frontiers to Cancer Care Symposium Lung Cancer Screening Update: Pros, Cons, and Understanding the CMS Requirements Mark S. Parker, M.D., F.A.C.R. Professor, Diagnostic Radiology

More information

HANDLING LUNG CANCER CLAIMS

HANDLING LUNG CANCER CLAIMS HANDLING LUNG CANCER CLAIMS JENNIFER S. KILPATRICK SWANSON, MARTIN & BELL, LLP 330 North Wabash Avenue Suite 3300 Chicago, Illinois 60611-3604 (312) 321-3517 (312) 321-0990 jkilpatrick@smbtrials.com 1

More information

PSA Testing for Prostate Cancer An information sheet for men considering a PSA Test

PSA Testing for Prostate Cancer An information sheet for men considering a PSA Test PSA Testing for Prostate Cancer An information sheet for men considering a PSA Test What is the aim of this leaflet? Prostate cancer is a serious condition. The PSA test, which can give an early indication

More information

Early detection through mammography. Early breast cancer detection improved chances of recovery

Early detection through mammography. Early breast cancer detection improved chances of recovery Early detection through mammography Early breast cancer detection improved chances of recovery Contents 03 Experts recommend breast screening (mammography) 04 What is mammogram? 05 What is screening? What

More information

Transcript for Asbestos Information for the Community

Transcript for Asbestos Information for the Community Welcome to the lecture on asbestos and its health effects for the community. My name is Dr. Vik Kapil and I come to you from the Centers for Disease Control and Prevention, Agency for Toxic Substances

More information

A Practical Guide to Advances in Staging and Treatment of NSCLC

A Practical Guide to Advances in Staging and Treatment of NSCLC A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging

More information

Asbestos Health Risks. Dr Andrew Pengilley Acting Chief Health Officer

Asbestos Health Risks. Dr Andrew Pengilley Acting Chief Health Officer Asbestos Health Risks Dr Andrew Pengilley Acting Chief Health Officer Asbestos Asbestos is a name given to several different fibrous minerals Three main commercial types are Chrysotile (white asbestos)

More information

Asbestos Diseases. What Is Asbestos?

Asbestos Diseases. What Is Asbestos? 1 Asbestos Diseases What Is Asbestos? Asbestos is a term applied to a group of minerals formed into rock and mined in a similar way to coal. In this form, asbestos is made up of strong, fine and flexible

More information

Lung Cancer Surveillance using low Dose CT scanning Where are We Now?

Lung Cancer Surveillance using low Dose CT scanning Where are We Now? Lung Cancer urveillance using low Dose CT scanning Where are We Now? cott wanson Professor Thoracic urgery Brigham and Women s Hospital and Harvard Medical chool Disclosures These slides were kindly provided

More information

American Medical Women s Association. Position Paper on Principals of Breast Cancer Screening

American Medical Women s Association. Position Paper on Principals of Breast Cancer Screening American Medical Women s Association Position Paper on Principals of Breast Cancer Screening Breast cancer affects one woman in eight in the United States and is the most common cancer diagnosed in women

More information

WA Asbestos Review Program

WA Asbestos Review Program WA Asbestos Review Program Dr Fraser Brims Consultant Respiratory Physician, SCGH, Head of Occupational and Respiratory Health Unit, LIWA Asbestos awareness week seminar, 2014 Introduction Asbestos and

More information

Radiology Workload and Follow-up Considerations

Radiology Workload and Follow-up Considerations Radiology Workload and Follow-up Considerations William C. Black, MD Department of Radiology Norris Cotton Cancer Center Dartmouth-Hitchcock Medical Center william.c.black@hitchcock.org No financial disclosures

More information

TREATING LUNG CANCER AT VA PITTSBURGH HEALTHCARE SYSTEM A HERO S GUIDE

TREATING LUNG CANCER AT VA PITTSBURGH HEALTHCARE SYSTEM A HERO S GUIDE Providing the best in cancer care for Veterans TREATING LUNG CANCER AT VA PITTSBURGH HEALTHCARE SYSTEM A HERO S GUIDE VA Pittsburgh s state-of-the-art TomoTherapy machine, which delivers radiation to patients.

More information

HEALTH EFFECTS. Inhalation

HEALTH EFFECTS. Inhalation Health Effects HEALTH EFFECTS Asbestos can kill you. You must take extra precautions when you work with asbestos. Just because you do not notice any problems while you are working with asbestos, it still

More information

Recruiting now. Could you help by joining this study?

Recruiting now. Could you help by joining this study? Non-Small Cell Lung Cancer Recruiting now AstraZeneca is looking for men and women with locally advanced or metastatic non-small cell lung cancer (NSCLC) to join ATLANTIC, a clinical study to help investigate

More information

LUNG CANCER EVALUATION & TREATMENT. LungCancer. Prevention & Early Detection Save Lives. The Power Is Yours.

LUNG CANCER EVALUATION & TREATMENT. LungCancer. Prevention & Early Detection Save Lives. The Power Is Yours. LUNG CANCER EVALUATION & TREATMENT LungCancer Prevention & Early Detection Save Lives. The Power Is Yours. Prevention Lung cancer. It s one of the most common cancers in both men and women more deadly

More information

Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines

Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines April 2008 (presented at 6/12/08 cancer committee meeting) By Shelly Smits, RHIT, CCS, CTR Conclusions by Dr. Ian Thompson, MD Dr. James

More information

Lung Cancer: Diagnosis, Staging and Treatment

Lung Cancer: Diagnosis, Staging and Treatment PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer begins in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.

More information

Workers' Compensation in Japan

Workers' Compensation in Japan Table of Contents PL-5-02 Sugio Furuya Workers' Compensation in Japan Sugio Furuya Secretary General Japan Occupational Safety and Health Resource Center (JOSHRC) Abstract Each country has its own compensation

More information

Asbestos Claims Trust Page -1

Asbestos Claims Trust Page -1 Asbestos Claims Trust Page -1 Testimony of Dr. Laura Stewart Welch Medical Director Center to Protect Workers Rights June 4, 2003 Testimony of Laura Welch, MD Medical Director, Center to Protect Workers

More information

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available. Lung Cancer Introduction Lung cancer is the number one cancer killer of men and women. Over 165,000 people die of lung cancer every year in the United States. Most cases of lung cancer are related to cigarette

More information

Lung Cancer: Diagnosis, Staging and Treatment

Lung Cancer: Diagnosis, Staging and Treatment PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer starts in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.

More information

PSA Screening and the USPSTF Understanding the Controversy

PSA Screening and the USPSTF Understanding the Controversy PSA Screening and the USPSTF Understanding the Controversy Peter C. Albertsen Division of Urology University of Connecticut Farmington, CT, USA USPSTF Final Report 1 Four Key Questions 1. Does PSA based

More information

Asbestos and your lungs

Asbestos and your lungs This information describes what asbestos is and the lung conditions that are caused by exposure to it. It also includes information about what to do if you have been exposed to asbestos, and the benefits

More information

Small Cell Lung Cancer

Small Cell Lung Cancer Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually

More information

Clinical Indications and Results Following Chest Wall Resection

Clinical Indications and Results Following Chest Wall Resection Clinical Indications and Results Following Chest Wall Resection for Recurrent Malignant Pleural Mesothelioma Ali SO, Burt BM, Groth SS, DaSilva MC, Yeap BY, Richards WG, Baldini EH and Sugarbaker DJ. Division

More information

Lungenkrebs. Lungenkrebs Häufigkeit

Lungenkrebs. Lungenkrebs Häufigkeit Lungenkrebs Prof. Dr. E.W. Russi Pneumologie 1.9.2008 Lungenkrebs Häufigkeit The Principles and Practice of Medicine William Osler New York D. Appleton and Company 1892 Section IV DISEASE OF THE RESPIRATORY

More information

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012 Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos

More information

NHS Barking and Dagenham Briefing on disease linked to Asbestos in Barking & Dagenham

NHS Barking and Dagenham Briefing on disease linked to Asbestos in Barking & Dagenham APPENDIX 1 NHS Barking and Dagenham Briefing on disease linked to Asbestos in Barking & Dagenham 1. Background 1.1. Asbestos Asbestos is a general name given to several naturally occurring fibrous minerals

More information

PSA Screening for Prostate Cancer Information for Care Providers

PSA Screening for Prostate Cancer Information for Care Providers All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits

More information

The AMIANTUS programme of prophylactic medical examinations of the former asbestos workers in:

The AMIANTUS programme of prophylactic medical examinations of the former asbestos workers in: Reference Centre for Asbestos Exposure &Health Risk Assessment The AMIANTUS programme of prophylactic medical examinations of the former asbestos workers in: NEONILA SZESZENIA-DĄBROWSKA, BEATA ŚWIŚTKOWSKA,

More information

International Journal of Case Reports in Medicine

International Journal of Case Reports in Medicine International Journal of Case Reports in Medicine Vol. 2013 (2013), Article ID 409830, 15 minipages. DOI:10.5171/2013.409830 www.ibimapublishing.com Copyright 2013 Andrew Thomas Low, Iain Smith and Simon

More information

Testimony of. Laura Welch, M.D. Medical Director Center to Protect Workers Rights November 17, 2005

Testimony of. Laura Welch, M.D. Medical Director Center to Protect Workers Rights November 17, 2005 Testimony of Laura Welch, M.D. Medical Director Center to Protect Workers Rights November 17, 2005 Testimony of Laura Welch, MD Medical Director, Center to Protect Workers Rights On Asbestos Related Diseases

More information

Lung Cancer Awareness Month Update

Lung Cancer Awareness Month Update Lung Cancer Awareness Month Update Guest Expert: Frank, MD Professor of Thoracic Surgery Lynn, MD Professor of Pulmonary Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers

More information

BAISHIDENG PUBLISHING GROUP INC

BAISHIDENG PUBLISHING GROUP INC Reviewer s code: 01714224 Reviewer s country: Italy Date reviewed: 2015-01-30 20:36 [ Y] Grade A: Priority publishing [ ] Accept [ ] Grade C: Good [ Y] Grade D: Fair language [ Y] Major revision The article

More information

incidence rates of other cancers. The word mesothelioma is derived from the English word

incidence rates of other cancers. The word mesothelioma is derived from the English word Mesothelioma is a devastating form of cancer that is relatively rare when compared to the incidence rates of other cancers. The word mesothelioma is derived from the English word mesothelium, which is

More information

Screening, early referral and treatment for asbestos related cancer

Screening, early referral and treatment for asbestos related cancer Screening, early referral and treatment for asbestos related cancer Marc de Perrot, MD, MSc, FRCSC Toronto Mesothelioma Research Program University of Toronto Asbestos related diseases Mesothelioma Lung

More information

Patient sample criteria for the OPEIR Measures Group are all patients regardless of age, that have a specific CT procedure performed:

Patient sample criteria for the OPEIR Measures Group are all patients regardless of age, that have a specific CT procedure performed: OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES GROUP OVERVIEW 2016 PQRS OPTIONS F MEASURES GROUPS: 2016 PQRS MEASURES IN OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES

More information

Kidney Cancer OVERVIEW

Kidney Cancer OVERVIEW Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney

More information

Prostate Cancer Screening in Taiwan: a must

Prostate Cancer Screening in Taiwan: a must Prostate Cancer Screening in Taiwan: a must 吳 俊 德 基 隆 長 庚 醫 院 台 灣 醫 學 會 105 th What is the PSA test? The blood level of PSA is often elevated in men with prostate cancer, and the PSA test was originally

More information

Asbestos related disease compensation. no-one can change the past, but one of us could change your future

Asbestos related disease compensation. no-one can change the past, but one of us could change your future Asbestos related disease compensation no-one can change the past, but one of us could change your future Although asbestos was introduced into the UK in the 19th century, it s only in the last few decades

More information

ROUND TABLE ADVANCES IN OCCUPATIONAL CANCER

ROUND TABLE ADVANCES IN OCCUPATIONAL CANCER ROUND TABLE ADVANCES IN OCCUPATIONAL CANCER OCCUPATIONAL CANCER EPIDEMIOLOGY Round Table organized by the Public Health Institute from Bucharest Information pack for the participants, provided by dr. Dana

More information

MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology

MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology MesoPDT Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI Image Assisted Laser Therapy for Oncology Unité Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI "Image

More information

OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS FOR MEASURES GROUPS:

OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS FOR MEASURES GROUPS: OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES

More information

Retrieved September 15, 2006 from

Retrieved September 15, 2006 from Cancer Health Cancer is not one disease, but a class of diseases characterized by uncontrolled cell division and the ability of those cells to invade other cells. Only a few decades ago many people thought

More information

PROSTATE CANCER SCREENING PROSTATE CANCER SCREENING

PROSTATE CANCER SCREENING PROSTATE CANCER SCREENING 3:45 4:45pm Screening Guidelines for Men's Health SPEAKER Radha Rao, MD Presenter Disclosure Information The following relationships exist related to this presentation: Radha Rao, MD: No financial relationships

More information

Providing Guidance on Lung Cancer Screening to Patients and Physicians

Providing Guidance on Lung Cancer Screening to Patients and Physicians Providing Guidance on Lung Cancer Screening to Patients and Physicians An Update from the American Lung Association Lung Cancer Screening Committee April 30, 2015 Executive Summary Lung cancer kills more

More information

FAQ About Prostate Cancer Treatment and SpaceOAR System

FAQ About Prostate Cancer Treatment and SpaceOAR System FAQ About Prostate Cancer Treatment and SpaceOAR System P. 4 Prostate Cancer Background SpaceOAR Frequently Asked Questions (FAQ) 1. What is prostate cancer? The vast majority of prostate cancers develop

More information

Guidelines for Management of Renal Cancer

Guidelines for Management of Renal Cancer Guidelines for Management of Renal Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Versions 2 and 3 Section 5 updated bullets 5.3 and 5.4 Section 6 updated

More information

Tricia Cox on 7/18/2012 at Oncology Center. Sarah Randolf. Female

Tricia Cox on 7/18/2012 at Oncology Center. Sarah Randolf. Female SAMPLE This Survivorship Care Plan will facilitate cancer care following active treatment. It may include important contact information, a treatment summary, recommendations for follow-up care testing,

More information